Pharmaceuticals Stocks

Abbott Laboratories Quarterly Stock Valuation – September 2014 $ABT

Abbott Laboratories is suitable for either the Defensive Investor or the Enterprising Investor. The Defensive Investor’s only initial concern is the low current ratio while the Enterprising Investor’s only concern is the lack of earnings growth over the last five years.

Read More
Back To Top